Please provide your email address to receive an email when new articles are posted on . One in six participants in phase 2 cancer trials received a therapy that gained FDA approval. The results ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially first-in-class therapeutics for common ...
Rentosertib, an AI-discovered TNIK inhibitor, showed safety and tolerability in a phase 2a trial for idiopathic pulmonary fibrosis. The trial involved 71 patients, with similar adverse event rates ...
Hosted on MSN
Funds approved for phase 2 of co-payment scheme
The government plans to use the central budget to fund the second phase of the popular 'Khon La Khrueng Plus' co-payment scheme to stimulate consumption. Prime Minister Anutin Charnvirakul directed ...
Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...
Good morning, ladies and gentlemen, and welcome to the Eledon Pharmaceuticals Phase II BESTOW Results Conference Call. [Operator Instructions] This call is being recorded on Friday, November 7, 2025.
Maridebart cafraglutide (Amgen), also known as MariTide or AMG133, helps patients with obesity—whether or not they also have diabetes—lose substantial amounts of body weight, according to newly ...
Kerala government has deferred the launch of phase two of the Medical Insurance Scheme for State Employees and Pensioners (Medisep) because of technical issues. The phase one will continue for the ...
Phase 2 trial results show XPro™ benefits cognition in certain early Alzheimer's patients, pending further data analysis and FDA designation. INmune Bio Inc. announced results from its Phase 2 MINDFuL ...
Maridebart cafraglutide showed up to 19.9% weight loss in obesity and 17% in obesity-diabetes patients in a phase 2 trial. The drug's 21-day half-life, combining GLP-1 receptor agonism and GIP ...
MEDISEP Phase II launches January 1, 2026, with increased premiums and coverage, facing criticism from employees over hospital access.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback